tiprankstipranks
Medical Net,Inc. (JP:3645)
:3645
Japanese Market
3645
Medical Net,Inc.
RESEARCH TOOLSreports
Want to see JP:3645 full AI Analyst Report?

Medical Net,Inc. (3645) Ratios

0 Followers

Medical Net,Inc. Ratios

JP:3645's free cash flow for Q4 2024 was ¥0.30. For the 2024 fiscal year, JP:3645's free cash flow was decreased by ¥ and operating cash flow was ¥0.02. See a summary of the company’s cash flow.
Ratios
TTM
May 24May 23May 22May 21
Liquidity Ratios
Current Ratio
 1.64 1.53 1.75 1.71 1.60
Quick Ratio
 1.50 1.37 1.62 1.62 1.50
Cash Ratio
 0.93 0.75 0.94 1.06 0.87
Solvency Ratio
 0.11 <0.01 0.03 0.12 0.29
Operating Cash Flow Ratio
 0.00 -0.04 0.07 0.30 0.26
Short-Term Operating Cash Flow Coverage
 0.00 -0.09 0.19 0.61 0.52
Net Current Asset Value
¥ 1.03B¥ 646.39M¥ 777.32M¥ 921.23M¥ 661.08M
Leverage Ratios
Debt-to-Assets Ratio
 0.29 0.31 0.26 0.23 0.25
Debt-to-Equity Ratio
 0.66 0.73 0.54 0.41 0.45
Debt-to-Capital Ratio
 0.40 0.42 0.35 0.29 0.31
Long-Term Debt-to-Capital Ratio
 0.13 0.16 0.17 0.04 0.06
Financial Leverage Ratio
 2.28 2.38 2.09 1.81 1.85
Debt Service Coverage Ratio
 0.16 0.12 0.13 0.24 0.65
Interest Coverage Ratio
 11.78 8.16 46.45 125.46 225.49
Debt to Market Cap
 0.46 0.44 0.31 0.22 0.19
Interest Debt Per Share
 142.53 142.20 114.52 88.59 88.62
Net Debt to EBITDA
 -2.84 -1.16 -2.34 -2.30 -0.63
Profitability Margins
Gross Profit Margin
30.04%32.28%35.05%39.57%38.98%
EBIT Margin
2.42%1.55%3.04%5.64%14.30%
EBITDA Margin
3.59%2.81%4.06%7.02%15.24%
Operating Profit Margin
2.42%1.55%5.68%8.44%11.88%
Pretax Profit Margin
4.54%0.41%2.91%5.57%14.25%
Net Profit Margin
3.06%-1.12%0.11%2.58%10.15%
Continuous Operations Profit Margin
3.45%-0.62%0.50%2.42%10.57%
Net Income Per EBT
67.48%-270.55%3.89%46.33%71.21%
EBT Per EBIT
187.45%26.72%51.31%66.05%119.92%
Return on Assets (ROA)
4.47%-1.67%0.15%3.35%12.07%
Return on Equity (ROE)
10.76%-3.97%0.31%6.06%22.32%
Return on Capital Employed (ROCE)
6.69%4.39%12.60%18.71%24.07%
Return on Invested Capital (ROIC)
3.57%-4.59%1.71%6.02%13.15%
Return on Tangible Assets
4.94%-1.87%0.17%3.67%14.20%
Earnings Yield
7.17%-2.41%0.18%3.30%9.32%
Efficiency Ratios
Receivables Turnover
 6.72 6.87 6.30 6.67 5.64
Payables Turnover
 9.59 10.05 7.82 8.42 8.80
Inventory Turnover
 15.40 12.91 16.53 21.94 17.67
Fixed Asset Turnover
 51.28 45.59 41.83 40.39 35.26
Asset Turnover
 1.46 1.49 1.32 1.30 1.19
Working Capital Turnover Ratio
 5.05 5.42 4.70 5.00 4.80
Cash Conversion Cycle
 39.99 45.08 33.35 28.00 43.93
Days of Sales Outstanding
 54.34 53.10 57.95 54.70 64.77
Days of Inventory Outstanding
 23.71 28.28 22.08 16.64 20.65
Days of Payables Outstanding
 38.06 36.30 46.68 43.34 41.49
Operating Cycle
 78.05 81.38 80.03 71.34 85.42
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 -9.06 13.22 47.89 39.15
Free Cash Flow Per Share
 0.00 -23.80 9.59 45.59 38.90
CapEx Per Share
 0.00 14.74 3.63 2.30 0.25
Free Cash Flow to Operating Cash Flow
 0.00 2.63 0.73 0.95 0.99
Dividend Paid and CapEx Coverage Ratio
 0.00 -0.51 2.16 7.69 9.41
Capital Expenditure Coverage Ratio
 0.00 -0.61 3.65 20.80 158.22
Operating Cash Flow Coverage Ratio
 0.00 -0.06 0.12 0.54 0.44
Operating Cash Flow to Sales Ratio
 0.00 -0.01 0.02 0.10 0.09
Free Cash Flow Yield
0.00%-7.51%2.61%11.60%8.35%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 13.94 -41.51 558.59 30.31 10.73
Price-to-Sales (P/S) Ratio
 0.43 0.47 0.63 0.78 1.09
Price-to-Book (P/B) Ratio
 1.42 1.65 1.75 1.84 2.39
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 -13.32 38.35 8.62 11.98
Price-to-Operating Cash Flow Ratio
 0.00 -34.99 27.83 8.21 11.90
Price-to-Earnings Growth (PEG) Ratio
 <0.01 0.03 -5.89 -0.43 0.06
Price-to-Fair Value
 1.42 1.65 1.75 1.84 2.39
Enterprise Value Multiple
 9.06 15.39 13.27 8.85 6.51
Enterprise Value
 2.15B 2.63B 2.83B 2.79B 3.72B
EV to EBITDA
 9.06 15.39 13.27 8.85 6.51
EV to Sales
 0.33 0.43 0.54 0.62 0.99
EV to Free Cash Flow
 0.00 -12.38 32.61 6.84 10.92
EV to Operating Cash Flow
 0.00 -32.53 23.66 6.51 10.85
Tangible Book Value Per Share
 175.43 150.23 162.69 181.13 143.98
Shareholders’ Equity Per Share
 214.72 192.26 210.85 213.93 194.63
Tax and Other Ratios
Effective Tax Rate
 0.24 2.49 0.83 0.57 0.26
Revenue Per Share
 714.38 680.32 580.64 502.28 428.05
Net Income Per Share
 21.88 -7.64 0.66 12.97 43.44
Tax Burden
 0.67 -2.71 0.04 0.46 0.71
Interest Burden
 1.87 0.27 0.96 0.99 1.00
Research & Development to Revenue
 <0.01 <0.01 <0.01 0.00 <0.01
SG&A to Revenue
 0.28 0.30 0.03 0.03 0.04
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.00 1.19 20.07 3.70 0.89
Currency in JPY